TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 3 | 4 | -9 | 19 | 5 | 26 | 8 |
| P | %wins | 100 | 100 | 0 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/1/20 08:34 | 8/26/20 | FBIO | Fortress Biotech, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hoenlein Malcolm | NY | D | P | 300 | 18.00 | 0 | 17 | New | 17 | D | |||||||||||||||
11/10/14 16:23 | 11/6/14 | CNDO | Coronado Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Hoenlein Malcolm | MA | D | P | 40 | 1.61 | 0 | 25 | 83 | 55 | D | |||||||||||||||
4/26/05 17:29 | 2/2/01 | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hoenlein Malcolm | NY | D | P.d | 19 | 9.62 | 4 | 2 | New | 2 | D | 985 | -25 | 22 | -9 | 9 | 1 | 4 | 4 | 3 | 4 | -9 | 19 | 5 | 26 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |